Health and Healthcare
730 Articles
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016…
ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering…
Jon OggMost investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position…
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late…
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…
Most Wall Street firms run model portfolios for their institutional and retail clients. Here are stocks that recently were added…
In a new research report, the analysts at Deutsche Bank unveil their "what to buy now ?" list for large…
With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…
24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…
Our top personal finance-related articles today. Your wallet will thank you later.